Paul Wallace Ph.D. has been appointed chief business officer at MISSION Therapeutics. Dr. Wallace will be responsible for the future business strategy for the company’s pipeline, exploring strategic options such as development partnerships.   Dr. Wallace has 20 years of business development experience and most recently served as executive vice president and head of business development at Medivir AB, and was a member of the executive management team. He was responsible for strategic and operatio...